Camostat

Camostat
Clinical data

AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
ATC code	B02AB04 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)phenylacetate
CAS Number	59721-28-7^Y
PubChem CID	2536
IUPHAR/BPS	6432
ChemSpider	2440^Y
UNII	0FD207WKDU
ChEMBL	CHEMBL590799^Y
Chemical and physical data
Formula	C₂₀H₂₂N₄O₅
Molar mass	398.41 g/mol
3D model (Jmol)	Interactive image
SMILES CN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N
InChI InChI=1S/C20H22N4O5/c1-24(2)17(25)12-28-18(26)11-13-3-9-16(10-4-13)29-19(27)14-5-7-15(8-6-14)23-20(21)22/h3-10H,11-12H2,1-2H3,(H4,21,22,23)^Y Key:XASIMHXSUQUHLV-UHFFFAOYSA-N^Y

Camostat (INN) or FOY-305 is a serine protease inhibitor. Serine protease enzymes have a variety of functions in the body, and so camostat has a diverse range of uses. It is used in the treatment of some forms of cancer and is also effective against some viral infections, as well as inhibiting fibrosis in liver or kidney disease or pancreatitis.

...
Wikipedia